Minimal Residual Disease (MRD) ratio before and after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

被引：0

作者：

Boncompagni, Riccardo ^{[1
]}

Staderini, Michela ^{[2
]}

Nozzoli, Chiara ^{[1
]}

Antonioli, Elisabetta ^{[2
]}

Caporale, Roberto ^{[3
]}

Peruzzi, Benedetta ^{[3
]}

Cutini, Ilaria ^{[1
]}

Gozzini, Antonella ^{[1
]}

Serena, Mariotti ^{[1
]}

Guidi, Stefano ^{[1
]}

Jance, Blerina ^{[3
]}

Accogli, Barbara ^{[2
]}

Francesco, Annunziato ^{[3
]}

Bosi, Alberto ^{[2
]}

Saccardi, Riccardo ^{[1
]}

机构：

[1] AOU Careggi, Cell Therapy & Transfus Med Unit, Florence, Italy

[2] AOU Careggi, Hematol Unit, Florence, Italy

[3] AOU Careggi, Diagnost Ctr Cytometry & Immunotherapy, Florence, Italy

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

autologous stem cell transplant; Minimal residual disease; Progression-free survival;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

FP-203

引用

页码：E172 / E172

页数：1

共 50 条

[31] Impact of minimal residual disease detection after treatment of multiple myeloma
Szendrei Tamas
Plander Mark
Szabo Zsuzsanna
Kereskai Laszlo
Kajtar Bela
Papp Gergely
Ivanyi Janos Laszlo
ORVOSI HETILAP, 2019, 160 (13) : 502 - 508
[32] Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation
Martinelli, G
Terragna, C
Zamagni, E
Ronconi, S
Tosi, P
Lemoli, RM
Bandini, G
Testoni, N
Amabile, M
Ottaviani, E
Buonamici, S
Soverini, S
Montefusco, V
De Vivo, A
Bonifazi, F
Tura, S
Cavo, M
HAEMATOLOGICA, 2000, 85 (09) : 930 - 934
[33] Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma
Bal, Susan
Landau, Heather J.
Shah, Gunjan L.
Scordo, Michael
Dahi, Parastoo
Lahoud, Oscar B.
Hassoun, Hani
Hultcrantz, Malin
Korde, Neha
Lendvai, Nikoletta
Lesokhin, Alexander M.
Mailankody, Sham
Shah, Urvi A.
Smith, Eric
Devlin, Sean M.
Avecilla, Scott
Dogan, Ahmet
Roshal, Mikhail
Landgren, Ola
Giralt, Sergio A.
Chung, David J.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1394 - 1401
[34] Multiple myeloma, immunotherapy and minimal residual disease
Kusenda, J.
Kovarikova, A.
NEOPLASMA, 2016, 63 (05) : 651 - 658
[35] Standardisation of minimal residual disease in multiple myeloma
Innao, V.
Allegra, A.
Russo, S.
Gerace, D.
Vaddinelli, D.
Alonci, A.
Allegra, A. G.
Musolino, C.
EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
[36] The future of autologous stem cell transplantation in myeloma
van Rhee, Frits
Giralt, Sergio
Barlogie, Bart
BLOOD, 2014, 124 (03) : 328 - 333
[37] Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation
Hsu, Te-Lin
Tsai, Chun-Kuang
Liu, Chun-Yu
Yeh, Chiu-Mei
Lin, Fen-Lan
Hsiao, Liang-Tsai
Liu, Yao-Chung
Chien, Sheng-Hsuan
Wang, Hao-Yuan
Ko, Po-Shen
Lin, Ting-An
Chen, Wen-Chun
Chen, Po-Min
Liu, Jin-Hwang
Gau, Jyh-Pyng
Liu, Chia-Jen
ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2893 - 2904
[38] Bone Marrow Plasma Cell Assessment before Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Lee, Sung-Eun
Yoon, Jae-Ho
Shin, Seung-Hwan
Eom, Ki-Seong
Kim, Yoo-Jin
Kim, Hee-Je
Lee, Seok
Cho, Seok-Goo
Lee, Jong Wook
Min, Woo-Sung
Park, Chong-Won
Kim, Myungshin
Min, Chang-Ki
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[39] Complete response after autologous stem cell transplant in multiple myeloma
Kumar, Lalit
Iqbal, Nida
Mookerjee, Anjali
Verma, Rakesh Kumar
Sharma, Om D.
Batra, Atul
Pramanik, Raja
Gupta, Ritu
CANCER MEDICINE, 2014, 3 (04): : 939 - 946
[40] Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Therapies
Parrondo, Ricardo D.
Ailawadhi, Sikander
Sher, Taimur
Chanan-Khan, Asher A.
Roy, Vivek
JCO ONCOLOGY PRACTICE, 2020, 16 (02) : 56 - +

← 1 2 3 4 5 →